SA
CME icon

Strategic Advocates’s CME Group CME Stock Holding History

Strategic Advocates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Sell
37
-1,739
-98% -$517K 0.05% 153
2025
Q4 		$490K Sell
1,776
-154
-8% -$41.8K 0.13% 76
2025
Q3 		$521K Buy
1,930
+23
+1% +$6.26K 0.14% 78
2025
Q2 		$526K Buy
1,907
+57
+3% +$15.5K 0.16% 74
2025
Q1 		$491K Sell
1,850
-358
-16% -$88.3K 0.17% 68
2024
Q4 		$513K Buy
2,208
+382
+21% +$87.8K 0.17% 63
2024
Q3 		$403K Buy
1,826
+415
+29% +$85.9K 0.14% 84
2024
Q2 		$277K Buy
1,411
+152
+12% +$31.4K 0.11% 97
2024
Q1 		$271K Buy
+1,259
New +$264K 0.1% 104

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Strategic Advocates's CME Position: Q1 2026 in Review

Strategic Advocates reduced its CME Group (CME) stake by 98% in Q1 2026, selling an estimated $517K and leaving 37 shares worth $10.9K. The position accounts for 0.05% of the portfolio, ranked #153.

Strategic Advocates first reported a position in CME in Q1 2024 and has held it in 9 quarters since. The position peaked at $526K in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Strategic Advocates held 37 shares of CME Group worth $10.9K as of Q1 2026.
  • Strategic Advocates sold 1,739 CME Group shares in Q1 2026, an estimated $517K.
  • CME Group made up 0.05% of Strategic Advocates's portfolio in Q1 2026, its #153 holding.
  • Strategic Advocates first reported a position in CME Group in Q1 2024 and has held it in 9 quarters since.
  • Strategic Advocates's CME Group position peaked at $526K in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.